Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05289869 · ClinicalTrials.gov registry record · Phase 4
A Pilot Study: High Versus Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity
A Phase 4 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT05289869 is a Phase 4 study that has completed, run by Ohio State University. The registered enrollment target is 20 participants.
The verdict
NCT05289869, a Phase 4 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Pregnant patients with obesity are more likely to undergo induction of labor and have a higher risk of failed induction compared to patients with normal weight. The association between maternal obesity and labor dysfunction leading to cesarean delivery is poorly understood. Oxytocin is the mostly common medication used in induction of labor, yet optimal dosing of this medication is unknown. Studies have suggested that patients with obesity may be less responsive to oxytocin. This trial will compare a high and low dose oxytocin dosing regimen for the induction of labor in women with obesity.
Interventions
- DRUG High-dose oxytocin
- DRUG Low-dose oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-04-06 |
| Est. Completion | 2022-10-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05289869
The ClinicalTrials.gov registry entry for NCT05289869 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High-dose oxytocin is the first listed.
NCT05289869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05289869 about?
NCT05289869 is a clinical study titled "A Pilot Study: High Versus Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity". Pregnant patients with obesity are more likely to undergo induction of labor and have a higher risk of failed induction compared to patients with normal weight. The association between maternal obesity and labor dysfunction leading to cesarean delivery is poorly understood. Oxytocin is the mostly co...
What is the current status of trial NCT05289869?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2022-04-06. Estimated completion is 2022-10-28.
What interventions are being tested in trial NCT05289869?
The interventions under investigation include: High-dose oxytocin (DRUG), Low-dose oxytocin (DRUG).
Who is sponsoring clinical trial NCT05289869?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.